Strumento inattivo

Azioni CoLucid Pharmaceuticals Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

CoLucid Pharmaceuticals : Lilly Completes Acquisition of CoLucid Pharmaceuticals	01/03/17
Bragar Eagel & Squire, P.C. : Is Investigating the Board of Directors of CoLucid Pharmaceuticals, Inc. (CLCD) on Behalf of Stockholders and Encourages Investors to Contact the Firm	31/01/17
Brower Piven Commences An Investigation Into The Proposed Sale Of CoLucid Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	30/01/17
Brower Piven Commences An Investigation Into The Proposed Sale Of CoLucid Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	23/01/17
COLUCID PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Believes the Acquisition by Eli Lilly and Company May be Unfair to Shareholders	18/01/17

Settore